SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-23-037370
Filing Date
2023-03-28
Accepted
2023-03-28 07:00:32
Documents
14
Period of Report
2023-03-27
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2310615d2_8k.htm   iXBRL 8-K 34275
2 EXHIBIT 99.1 tm2310615d2_ex99-1.htm EX-99.1 16614
6 GRAPHIC tm2310615d2_ex99-1img001.jpg GRAPHIC 17392
  Complete submission text file 0001104659-23-037370.txt   262387

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA mist-20230327.xsd EX-101.SCH 3055
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE mist-20230327_lab.xml EX-101.LAB 34477
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mist-20230327_pre.xml EX-101.PRE 22610
8 EXTRACTED XBRL INSTANCE DOCUMENT tm2310615d2_8k_htm.xml XML 3875
Mailing Address 1111 BOUL. DR.-FREDERIK-PHILIPS, STE 420 MONTREAL A8 H4M 2X6
Business Address 1111 BOUL. DR.-FREDERIK-PHILIPS, STE 420 MONTREAL A8 H4M 2X6 (514) 336-0444
Milestone Pharmaceuticals Inc. (Filer) CIK: 0001408443 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A8 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38899 | Film No.: 23766113
SIC: 2834 Pharmaceutical Preparations